Immunodominant fragments of myelin basic protein initiate T cell-dependent pain

Huaqing Liu1, Sergey A Shiryaev, Andrei V Chernov

  • 1Department of Anesthesiology, University of California, San Diego, 9500 Gilman Dr., Mail Box 0629, La Jolla, CA 92093-0629, USA.

Abstract

Insights

Matrix metalloproteinases (MMPs) degrade myelin, causing pain. Myelin basic protein (MBP) peptides, generated by MMPs, trigger mechanical allodynia and neuroinflammation, potentially leading to chronic pain.

Area of Science:

  • Neuroscience
  • Immunology
  • Molecular Biology

Background:

  • Myelin sheath insulates nerve fibers, preventing pain signaling.
  • Matrix metalloproteinases (MMPs) degrade myelin, leading to nerve instability and mechanical allodynia.
  • Molecular mechanisms of neuropathic pain post-nerve injury are not fully understood.

Purpose of the Study:

  • Investigate the molecular mechanisms of neuropathic pain after nerve injury.
  • Identify the role of myelin degradation products in pain development.

Main Methods:

  • Sciatic nerve proteome analysis using mass spectrometry and bioinformatics.
  • Inhibition of MMP-9/MMP-2 to assess effects on mechanical allodynia and inflammation.
  • Administration of myelin basic protein (MBP) peptides to naïve nerves.
  • Genome-wide expression profiling.
  • Experiments using T cell-deficient athymic nude rats.

Main Results:

  • CCI activated infectious disease and T-helper cell signaling pathways.
  • MMP-9/MMP-2 inhibition reduced mechanical allodynia and TNF-α/IL-17A expression.
  • MMP-9 cleaved MBP into immunogenic peptides (MBP84-104, MBP68-86).
  • MBP peptide administration induced mechanical allodynia and immune cell infiltration.
  • MBP peptide injection activated inflammatory and antigen presentation pathways.

Conclusions:

  • MBP is a novel pain mediator.
  • MMP activity is crucial for tactile allodynia and neuroinflammation post-injury.
  • MBP peptides induce mechanical allodynia via T cell-dependent and -independent pathways.
  • Self-sustaining immune reactions to MBP epitopes may drive chronic pain development.

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Nociception01:44

Nociception

Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain. Thus, pain helps the...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...